Vladimir Makatsaria is the Chief Executive Officer of LivaNova PLC, a global medical technology company focused on delivering innovative therapies and solutions for cardiovascular and neuromodulation disorders. Before joining LivaNova, Makatsaria held various leadership positions in the healthcare industry, showcasing his expertise and commitment to advancing medical technology. He has a strong background in business development, strategy, and operations, which has been instrumental in driving LivaNova's growth and success. Prior to his role at LivaNova, Makatsaria served as the President of the Cardiac Rhythm Management business at Boston Scientific Corporation, where he led the global strategy and operations for the division. Under his leadership, the business experienced significant growth and innovation, solidifying its position as a leader in the cardiac rhythm management market. Makatsaria's strategic vision and ability to execute complex initiatives have been key factors in his successful career. As CEO of LivaNova, Makatsaria is responsible for overseeing the company's overall strategy, operations, and growth initiatives. He has been instrumental in driving the company's focus on developing innovative therapies and solutions that improve patient outcomes. Under his leadership, LivaNova has continued to expand its global presence and strengthen its position in the medical technology industry. Makatsaria's dedication to advancing healthcare and his proven track record of success make him a valuable asset to LivaNova and the patients it serves.